- Home
- RVP vs MIRA Comparison
RVP vs MIRA Comparison
Compare RVP & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVP
- MIRA
- Stock Information
- Founded
- RVP 1994
- MIRA 2020
- Country
- RVP United States
- MIRA United States
- Employees
- RVP N/A
- MIRA N/A
- Industry
- RVP Medical/Dental Instruments
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- RVP Health Care
- MIRA Health Care
- Exchange
- RVP Nasdaq
- MIRA Nasdaq
- Market Cap
- RVP 18.6M
- MIRA 18.4M
- IPO Year
- RVP 2001
- MIRA 2023
- Fundamental
- Price
- RVP $0.85
- MIRA $1.10
- Analyst Decision
- RVP
- MIRA Strong Buy
- Analyst Count
- RVP 0
- MIRA 2
- Target Price
- RVP N/A
- MIRA $14.00
- AVG Volume (30 Days)
- RVP 68.1K
- MIRA 226.5K
- Earning Date
- RVP 03-28-2025
- MIRA 03-31-2025
- Dividend Yield
- RVP N/A
- MIRA N/A
- EPS Growth
- RVP N/A
- MIRA N/A
- EPS
- RVP N/A
- MIRA N/A
- Revenue
- RVP $38,265,097.00
- MIRA N/A
- Revenue This Year
- RVP N/A
- MIRA N/A
- Revenue Next Year
- RVP N/A
- MIRA N/A
- P/E Ratio
- RVP N/A
- MIRA N/A
- Revenue Growth
- RVP N/A
- MIRA N/A
- 52 Week Low
- RVP $0.56
- MIRA $0.51
- 52 Week High
- RVP $1.34
- MIRA $5.01
- Technical
- Relative Strength Index (RSI)
- RVP 61.26
- MIRA 43.36
- Support Level
- RVP $0.77
- MIRA $1.09
- Resistance Level
- RVP $0.82
- MIRA $1.18
- Average True Range (ATR)
- RVP 0.04
- MIRA 0.06
- MACD
- RVP -0.00
- MIRA -0.00
- Stochastic Oscillator
- RVP 69.16
- MIRA 7.69
About RVP Retractable Technologies Inc.
Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to the Company's other products.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.